GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CellSource Co 4880.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

281

+3.69%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥3.71bn

FY2017FY2025

Net income

¥10.7m

FY2017FY2025

Free cash flow

¥289.9m

FY2017FY2025

Shareholders' equity

¥6.02bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥3.71bn¥4.36bn¥4.51bn¥4.27bn¥2.92bn¥1.86bn¥1.61bn¥1.21bn¥519.1m
Research and development¥19.1m¥71.0m¥72.5m¥87.6m¥71.2m¥10.8m¥8.0m¥6.9m¥4.1m
Operating income¥166.7m¥130.5m¥1.26bn¥1.57bn¥993.2m¥415.6m¥326.9m¥295.1m¥159.2m
Net income¥10.7m¥237.9m¥923.1m¥1.02bn¥651.4m¥274.1m¥199.6m¥193.4m¥111.4m
Diluted earnings per share0.5412.0147.5952.9733.9014.3011.559.725.60

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥7.11bn¥7.17bn¥6.89bn¥4.60bn¥3.37bn¥2.35bn¥1.85bn¥697.0m¥327.4m
Cash and short-term investments¥4.71bn¥4.32bn¥4.78bn¥3.12bn¥2.41bn¥1.76bn¥1.33bn¥252.9m¥129.7m
Total liabilities¥1.10bn¥1.13bn¥689.5m¥815.7m¥645.6m¥309.6m¥243.8m¥295.8m¥119.6m
Debt¥56.7m¥77.3m¥97.5m—¥1.1m¥4.3m¥7.3m——
Shareholders' equity¥6.02bn¥6.04bn¥6.20bn¥3.79bn¥2.72bn¥2.04bn¥1.61bn¥401.2m¥207.8m
Shares outstanding20m20m19m19m19m19m17m20m20m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥333.1m¥591.7m¥846.7m¥847.6m¥898.2m¥330.2m¥195.3m¥214.0m¥109.9m
Capital spending−¥43.2m−¥493.3m−¥348.1m−¥94.7m−¥54.8m−¥30.1m−¥50.1m−¥24.9m−¥7.9m
Free cash flow¥289.9m¥98.5m¥498.6m¥752.9m¥843.4m¥300.2m¥145.2m¥189.1m¥102.1m
Dividends paid−¥98.9m−¥393.6m—−¥1.1m−¥3.2m−¥3.0m———

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue¥781.9m¥915.6m¥860.0m¥893.4m¥997.6m¥971.3m¥849.2m¥1.01bn
Operating income¥53.5m¥66.1m¥59.6m¥43.4m¥106.3m¥79.2m−¥62.2m−¥259.0m
Net income¥103.3m¥37.6m¥33.6m−¥75.6m¥75.1m¥56.6m−¥45.5m−¥136.3m
Diluted earnings per share5.191.891.69-3.823.792.86-2.29-6.88
Cash from operations———¥333.0m————
Capital spending———−¥43.0m————
Free cash flow———¥290.0m————
Total assets¥6.95bn¥6.98bn¥6.89bn¥7.11bn¥7.31bn¥6.94bn¥6.88bn¥7.17bn
Cash and short-term investments¥4.73bn¥4.79bn¥4.63bn¥4.71bn¥4.63bn¥4.41bn¥4.26bn¥4.32bn
Debt———¥20.9m¥200.0m——¥20.6m
Shareholders' equity¥6.07bn¥5.99bn¥5.95bn¥6.02bn¥6.09bn¥5.95bn¥5.89bn¥6.04bn

Financial ratios

Data as of 9 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin4.5%3.0%27.1%36.8%34.0%22.4%
Net margin0.3%5.5%20.5%23.8%22.3%14.8%
Return on equity0.2%3.9%14.9%26.9%23.9%13.4%
Return on assets0.1%3.3%13.4%22.1%19.4%11.7%
Free cash flow yield6.1%17.6%19.8%15.8%15.9%6.0%
Revenue growth-14.8%-3.4%5.5%46.3%57.5%15.1%
Earnings growth-95.5%-74.2%-9.3%56.3%137.7%37.3%
Current ratio12.39x11.48x12.36x5.01x4.65x7.02x
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x
Equity ratio84.6%84.2%90.0%82.3%80.8%86.8%
Interest coverage126.87x94.83x3222.96x142823.09x7303.28x1452.98x
R&D as a share of sales0.5%1.6%1.6%2.0%2.4%0.6%
Buybacks as a share of market value-0.1%-2.1%-1.0%0.0%-0.2%-10.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.6%14.9%—
Operating income-52.7%-16.7%—
Net income-78.1%-47.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings—69.326.975.6160.2253.2108.7
Price to sales2.13.85.518.035.737.413.7

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 30 Oct 2025.

FY2025FY2024
Paid in the year10.0020.00
  • 3-for-1 split · 28 Oct 2021
  • 3-for-1 split · 29 Oct 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.